A 52-year-old man with type 2 diabetes mellitus presents with fatigue and nocturia for 3 months. His blood pressure is 148/92 mmHg. Laboratory investigations show: serum creatinine 1.8 mg/dL, blood urea nitrogen 42 mg/dL, serum potassium 5.2 mEq/L, and urine albumin-to-creatinine ratio 320 mg/g. His serum cystatin C is 1.6 mg/L. Which of the following best explains the discrepancy between his serum creatinine-based GFR estimate and his cystatin C-based GFR estimate in this clinical scenario?

Explanation

## Clinical Context This patient has diabetic nephropathy with significant proteinuria (UACR 320 mg/g) and reduced renal function. The key finding is a discrepancy between creatinine-based and cystatin C-based GFR estimates. ## Why Serum Creatinine May Underestimate GFR Decline **Key Point:** Serum creatinine is an unreliable marker of GFR when muscle mass is reduced, as creatinine production depends on skeletal muscle turnover. In this diabetic patient with: - Chronic disease (3 months of symptoms) - Likely reduced lean body mass (common in diabetes) - Advanced CKD (Cr 1.8 suggests Stage 3b–4) The serum creatinine may be falsely reassuring because less creatinine is being produced. This makes creatinine-based eGFR equations (MDRD, CKD-EPI) overestimate true GFR. **High-Yield:** Cystatin C is produced at a constant rate by all nucleated cells and is NOT dependent on muscle mass, making it superior in patients with: - Low muscle mass (elderly, cachexic, diabetic patients) - Amputees - Chronic wasting diseases ## Why Cystatin C-Based GFR Is More Accurate Here Cystatin C reflects true GFR more accurately in this scenario because: 1. It is freely filtered by the glomerulus 2. It is reabsorbed and catabolized by proximal tubule cells (minimal secretion) 3. Its serum concentration is independent of muscle mass, diet, and gender 4. It is not affected by inflammation or malnutrition **Clinical Pearl:** When creatinine-based GFR and cystatin C-based GFR diverge significantly, suspect reduced muscle mass. In this patient, the higher cystatin C value (suggesting lower true GFR) is more reliable for drug dosing and prognosis. ## Comparison Table: Creatinine vs. Cystatin C | Feature | Serum Creatinine | Cystatin C | | --- | --- | --- | | Source | Skeletal muscle | All nucleated cells | | Affected by muscle mass | Yes (major) | No | | Affected by diet | Yes (meat intake) | No | | Secretion by tubules | Yes (10–40%) | Minimal | | Accuracy in low muscle mass | Poor | Excellent | | Cost | Low | Higher | **Mnemonic: CYSTATIN** — **C**onstant production, **Y**ield independent of mass, **S**uperior in **T**hin patients, **A**ccurate in **T**ype 2 **I**nsufficiency, **N**ot muscle-dependent.